MEDICENNA THERAPEUTICS CORP (MDNA.CA) Stock Cash Flow
Canada - Toronto Stock Exchange - TSX:MDNA - CA58490H1073 - Common Stock
1.39 CAD
+0.02 (+1.46%)
| TTM (2025-6-30) | 2025 (2025-3-31) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -13.10M | -11.80M | -25.47M | -10.05M | -22.58M | |||
| Depreciation Amortization | 67.00K | 53.00K | 4.00K | 0.00 | 40.00K | |||
| Change In Working Capital | 1.71M | 1.31M | 741.00K | 2.41M | -1.84M | |||
| Other non cash items | -6.39M | -6.05M | 8.46M | -5.02M | 800.00K | |||
| OPERATING CASH FLOW | -17.71M | -16.49M | -16.26M | -12.66M | -23.58M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.00K | -33.00K | N/A | N/A | N/A | |||
| Other Investing Activity | N/A | N/A | N/A | 0.00 | 10.05M | |||
| INVESTING CASH FLOW | -2.00K | -33.00K | N/A | 0.00 | 10.05M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -19.00K | N/A | 0.00 | -40.00K | |||
| Stock Issued/Repurchased | 2.67M | 23.51M | 0.00 | 24.76M | 3.92M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 2.63M | 23.49M | 0.00 | 24.76M | 3.88M | |||
| Exchange Rate Effect | -92.00K | 888.00K | -354.00K | 960.00K | -180.00K | |||
| CHANGE IN CASH | -15.17M | 7.86M | -16.61M | 13.06M | -9.83M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -17.71M | -16.49M | -16.26M | -12.66M | -23.58M | |||
| Capital Expenditure | -2.00K | -33.00K | N/A | N/A | N/A | |||
| FREE CASH FLOW | -17.71M | -16.52M | -16.26M | -12.66M | -23.58M | |||
All data in CAD